The upregulation of PFKFB4 was reported in multiple cancer types and was associated with the aggressiveness of tumors such as in bladder cancer, breast cancer, lung cancer, and ovarian cancer [40,41,42,43]. Here, PFKFB4 is linked to breast carcinoma.